Source: FinanzNachrichten

Parnell Pharmaceuticals: Parnell Pharmaceuticals is Dedicated to Your Dog's Health, CEO Clip Video

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2015) - President and CEO, of Parnell Pharmaceuticals (NASDAQ: PARN), Robert Joseph tells us about this pharmaceutical company that is giv...

Read full article »
Parnell Pharmaceuticals's Competitors | Parnell Pharmaceuticals's News | Parnell Pharmaceuticals's Financials
Stay up-to-date with the latest news on Parnell Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Francis Parnell's photo - Co-Founder & CEO of Parnell Pharmaceuticals

Co-Founder & CEO

Francis Parnell

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Parnell Pharmaceuticals